Stege, Henner ; Haist, Maximilian 
; Schultheis, Michael ; Fleischer, Maria Isabel ; Mohr, Peter ; Meier, Friedegund ; Schadendorf, Dirk ; Ugurel, Selma ; Livingstone, Elisabeth ; Zimmer, Lisa ; Herbst, Rudolf ; Pföhler, Claudia ; Kähler, Katharina ; Weichenthal, Michael ; Terheyden, Patrick ; Nashan, Dorothée ; Debus, Dirk ; Kaatz, Martin ; Ziller, Fabian ; Haferkamp, Sebastian ; Forschner, Andrea ; Leiter, Ulrike ; Kreuter, Alexander ; Ulrich, Jens ; Kleemann, Johannes ; Bradfisch, Fabienne ; Grabbe, Stephan ; Loquai, Carmen
; Schultheis, Michael ; Fleischer, Maria Isabel ; Mohr, Peter ; Meier, Friedegund ; Schadendorf, Dirk ; Ugurel, Selma ; Livingstone, Elisabeth ; Zimmer, Lisa ; Herbst, Rudolf ; Pföhler, Claudia ; Kähler, Katharina ; Weichenthal, Michael ; Terheyden, Patrick ; Nashan, Dorothée ; Debus, Dirk ; Kaatz, Martin ; Ziller, Fabian ; Haferkamp, Sebastian ; Forschner, Andrea ; Leiter, Ulrike ; Kreuter, Alexander ; Ulrich, Jens ; Kleemann, Johannes ; Bradfisch, Fabienne ; Grabbe, Stephan ; Loquai, Carmen Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma—A Retrospective Multicenter ADOReg Study
Stege, Henner, Haist, Maximilian, Schultheis, Michael, Fleischer, Maria Isabel, Mohr, Peter, Meier, Friedegund, Schadendorf, Dirk, Ugurel, Selma, Livingstone, Elisabeth , Zimmer, Lisa , Herbst, Rudolf, Pföhler, Claudia, Kähler, Katharina, Weichenthal, Michael, Terheyden, Patrick, Nashan, Dorothée, Debus, Dirk, Kaatz, Martin, Ziller, Fabian, Haferkamp, Sebastian , Forschner, Andrea, Leiter, Ulrike, Kreuter, Alexander , Ulrich, Jens, Kleemann, Johannes, Bradfisch, Fabienne, Grabbe, Stephan and Loquai, Carmen
(2021)
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma—A Retrospective Multicenter ADOReg Study.
Cancers 13 (10), p. 2312.
Date of publication of this fulltext: 29 Feb 2024 12:36
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Cancers | ||||
| Publisher: | MDPI | ||||
|---|---|---|---|---|---|
| Place of Publication: | BASEL | ||||
| Volume: | 13 | ||||
| Number of Issue or Book Chapter: | 10 | ||||
| Page Range: | p. 2312 | ||||
| Date | 2021 | ||||
| Institutions | Medicine > Lehrstuhl für Dermatologie und Venerologie | ||||
| Identification Number |
| ||||
| Keywords | LONG-TERM SURVIVAL; PROGNOSTIC-FACTORS; INHIBITOR TREATMENT; INITIAL TREATMENT; OPEN-LABEL; VEMURAFENIB; IPILIMUMAB; RESISTANCE; EFFICACY; IMMUNOTHERAPY; targeted therapy; complete response; advanced melanoma; discontinuation; disease progression; second-line immunotherapy | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 56690 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric